Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional ... segment consists of Cardiology and Peripheral Interventions.

This is a strategic move poised to significantly expand the company’s cardiology portfolio. By paying $27.50 per share, Boston Scientific is offering a 38% premium over Silk Road's volume ...

The Express® LD iliac premounted stent system (Boston Scientific, MA, USA) is currently the only available premounted balloon-expandable stent that is approved by the US FDA for the treatment of ...